A Phase I Study of iPS Cell Generation From Patients With COPD

Location:

Rochester, Minn.

Trial status:

Open for Enrollment

Why is this study being done?

As part of the long-term goal of successfully implementing tissue regeneration strategies in an individualized manner for patients with thoracic diseases including, but not limited to: cystic fibrosis, pulmonary fibrosis and pulmonary hypertension, the investigators will assess the feasibility of collecting skin biopsies from patients undergoing surgery for thoracic disease, culturing skin fibroblasts from the biopsy, and reprogramming these skin fibroblasts into induced pluripotent cells.

Who is eligible to participate?

Inclusion Criteria: - Undergoing Thoracic Surgery - Presence of a Thoracic Disease

Last updated:

9/9/2014

NCT ID:

NCT01860898

IRB Number:

09-005334